At the news
? BULLISHIMPACT 7/10 INSIDER-BUY filed Aug 17, 2026 at 16:45 ET
Kura Oncology CEO Troy Wilson purchased 100,000 shares worth $1.11M on the open market at $11.12/share, representing a material insider conviction buy. This is a strong standalone bullish signal from the highest-ranking insider, particularly notable given the company's $966M market cap and the CEO's direct cash deployment.
- CEO Troy Wilson purchased 100,000 shares at $11.12/share for total consideration of $1,112,000
- Purchase represents approximately 0.12% of KURA's $966M market cap
- This is the only insider trade in the past 7 days and the only buy in the past 30 days
- CEO is the highest-ranking insider, making this a conviction buy signal
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access